ACE and congestive heart failure: In dogs, the activation of RAAS during CHF due to MMVD is well-documented, and, for this reason, similarly to humans, these animals are treated with ACE inhibitors and anti-aldosterone diuretic agents, such as spironolactone, to control symptoms and prevent ventricular remodeling [9].